Kura Oncology Inc

8 ott 2026, 20:07 UTC

Kura Oncology to hold an investor webcast on October 13 to discuss Caspian Therapeutics and KO-7246 data from the EASD Annual Meeting.

7 ott 2026, 19:45 UTC

Kura Oncology Inc. will co-host a webcast with Caspian Therapeutics on October 13, 2026, to discuss KO-7246's preclinical data for diabetes treatment.

5 ott 2026, 20:06 UTC

Shares of Kura Oncology Inc fell, despite UBS reiterating a Buy rating with a $15 price target, citing strong early execution metrics for the Komzifti launch.

1 ott 2026, 20:07 UTC

Kura Oncology Inc shares fell modestly amid broader declines in the biotechnology sector, influenced by selloffs in key holdings like Nektar Therapeutics.

29 set 2026, 20:07 UTC

Kura Oncology shares advanced after presenting preclinical data on KO-7246, a menin inhibitor showing promise for diabetes treatment at the European Diabetes Meeting.

24 set 2026, 20:07 UTC

Kura Oncology Inc's shares fell sharply, pulling back from Wednesday's close and settling near the bottom of its one-month trading range.

23 set 2026, 20:02 UTC

Kura Oncology Inc shares fell sharply, continuing a downward trend amid broader sector challenges and significant losses in the Direxion Daily S&P Biotech Bull 3X ETF.

22 set 2026, 23:01 UTC

Kura Oncology Inc saw a modest rise in after-market trading, peaking shortly after the regular session ended, despite remaining below its 20-day moving average.

21 set 2026, 19:25 UTC

Kura Oncology Inc shares fell sharply, currently trading below its 20-day moving average and near the lower end of its one-month range.

18 set 2026, 20:06 UTC

Kura Oncology Inc is seeing a slight increase in trading, moving higher since Thursday's close but remaining near the lower end of its one-month range.

17 set 2026, 20:08 UTC

Kura Oncology Inc shares are advancing today, supported by increased retail commentary, despite pulling back from a session high earlier in the session.

16 set 2026, 20:10 UTC

Kura Oncology Inc shares fell sharply after an early spike, closing significantly below its 20-day moving average and near the lower end of its one-month range.

15 set 2026, 22:02 UTC

Kura Oncology Inc shares are higher in after-market trading, recovering from a low to a notable high during the session. No specific news was identified.

14 set 2026, 20:13 UTC

Kura Oncology Inc shares are higher in after-market hours, though no specific news was identified. The price remains below its 20-day moving average.

10 set 2026, 20:03 UTC

Kura Oncology Inc shares are lower, continuing a three-day decline despite increasing sales and the approval of its menin inhibitor, KOMZIFTI.

9 set 2026, 22:41 UTC

Kura Oncology Inc shares are rising in after-market trading, reflecting positive momentum in the biotechnology sector despite earlier session declines.

8 set 2026, 20:02 UTC

Kura Oncology Inc shares are lower today, influenced by declines in the Biotechnology sector despite the appointment of a new Chief Financial Officer.

3 set 2026, 19:47 UTC

Kura Oncology Inc shares are lower today, with no specific news driving the decline. Earlier, the stock rebounded from a session high.

2 set 2026, 22:01 UTC

Kura Oncology Inc shares are higher in after-market trading, reflecting strength amid weaker-than-expected job growth reported by ADP.

28 ago 2026, 20:08 UTC

Kura Oncology Inc shares are lower today, reflecting broader market trends and rising U.S. Treasury yields amid concerns over inflation and monetary policy.

27 ago 2026, 23:46 UTC

Kura Oncology Inc shares are higher in after-market hours, rebounding from earlier declines and staying above recent moving averages. No specific news was identified.

26 ago 2026, 23:41 UTC

Kura Oncology Inc shares are higher in after-market trading, supported by positive market sentiment despite no specific company news.

25 ago 2026, 23:06 UTC

Kura Oncology Inc. reached a new 52-week high after CEO Troy Wilson acquired 100,000 shares for approximately $1.24 million, reflecting strong market sentiment.

24 ago 2026, 23:31 UTC

Kura Oncology shares are higher in after-market hours following CEO Troy Wilson's $1.2 million stock purchase, boosting his ownership to 1.214 million shares.

21 ago 2026, 22:56 UTC

Kura Oncology shares declined in after-market trading, continuing a downward trend since Friday's close, despite remaining above the 20-day moving average.

20 ago 2026, 23:16 UTC

Kura Oncology Inc shares are higher in after-market trading, despite no specific news to explain the move. The stock remains above its 20-day moving average.

19 ago 2026, 19:21 UTC

Kura Oncology Inc shares are higher, supported by positive biotechnology sentiment and social media discussions about a recent swing position at $12.57.

18 ago 2026, 23:06 UTC

Kura Oncology shares are higher in after-market trading, aligning with broader market trends amid rising sovereign bond yields and inflation concerns.

17 ago 2026, 22:51 UTC

Kura Oncology shares rose in after-market trading after CEO Troy Wilson's $1.11 million stock purchase and positive earnings report highlighting $9.1 million in revenue.

14 ago 2026, 22:01 UTC

Kura Oncology Inc shares are higher in after-market trading, recovering from an earlier decline. The stock remains above its 20-day moving average.